ASPET’s Publications Committee is pleased to announce that Dr. Ai-Ming Yu has been selected to serve on the Publications Committee as an at-large member. His term is effective January 1, 2023 and runs through December 31, 2025.
Dr. Yu is a tenured Professor in the Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine. He obtained his B.S. at Central China Normal University in 1993 and Ph.D. at Nankai University in 1998. After completing his postdoctoral training at University of Washington (1998-2000) and West Virginia University (2000-2002) as well as a Research Fellow position at National Cancer Institute (2002-2004), Dr. Yu became an Assistant Professor at SUNY-Buffalo School of Pharmacy and Pharmaceutical Sciences in 2004, and he was tenured and promoted to Associate Professor in 2010. Dr. Yu moved to UC Davis School of Medicine in 2013, and he became a Full Professor in 2016.
He has been an ASPET member since 2008 and has served in various capacities, including Member, Programming Committee (2019-22), DMDD Chair (2018-2021), DMDD Communication Officer (2014-2015), President of Upstate New York Pharmacology Society of ASPET (2012-14), and DMDD Councilor (2010-14). His current editorial responsibilities include DMD, Acta Pharmaceutica Sinica B (APSB), and Pharmacogenomics Research and Personalized Medicine. His previous editorial experience includes Guess Editor of the Research Topic Post-transcriptional Regulation and Its Misregulation, Frontiers in Cell and Developmental Biology (2022); the Special Issue on RNA Therapeutics, Biochemical Pharmacology (2021); Guess Editor of the Special Issue on Drug Metabolism and Transport, APSB (2016); EAB member, DMD (2013-2018); AE of MicroRNA (2012-2020) and Frontiers in Bioengineering and Biotechnology (2018-2022), and others.